Please assess the completion status of the following clinical trial:

Trial Title: Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Obese patient (BMI\>30)~* American Society of Anesthesiologists grades II or III~* Diagnosis of impaired glucose tolerance~* Undergoing sleeve gastrectomy~Exclusion Criteria:~* Baseline glucose \> 200mg/dl~* Diagnosis of Diabetes~* Under corticosteroids treatment~* Oral hypoglycemic medication within 7 days previous surgery~* Use of insulin within 24h previous surgery~* Allergy to any drug used in the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Dexmedetomidine (Type: EXPERIMENTAL): After anesthesia induction, patients who were randomized to the Dexmedetomidine group received a bolus of 1ug/kg in 10 minutes, followed by an infusion of 0.5ug/kg/h until the end of surgery. In the case of intraoperative increment of the blood pressure and/or heart rate more than 25% from its baseline, fentanyl 1ug/kg was administered.
- 0.9% Sodium-chloride (Type: PLACEBO_COMPARATOR): After anesthesia induction, patients who were randomized to the Placebo group received a bolus and infusion of 0.9% normal saline at the same rate as the Dexmedetomidine group until the end of surgery. In the case of intraoperative increment of the blood pressure and/or heart rate more than 25% from its baseline, fentanyl 1ug/kg was administered.

Based on this trial design, predict the completion outcome and termination type (if applicable).